Correlation Between SAB Biotherapeutics and Coherus BioSciences
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Coherus BioSciences, you can compare the effects of market volatilities on SAB Biotherapeutics and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Coherus BioSciences.
Diversification Opportunities for SAB Biotherapeutics and Coherus BioSciences
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Coherus is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Coherus BioSciences go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Coherus BioSciences
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 5.29 times less return on investment than Coherus BioSciences. But when comparing it to its historical volatility, SAB Biotherapeutics is 1.04 times less risky than Coherus BioSciences. It trades about 0.06 of its potential returns per unit of risk. Coherus BioSciences is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 72.00 in Coherus BioSciences on August 28, 2024 and sell it today you would earn a total of 49.00 from holding Coherus BioSciences or generate 68.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Coherus BioSciences
Performance |
| Timeline |
| SAB Biotherapeutics |
| Coherus BioSciences |
SAB Biotherapeutics and Coherus BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Coherus BioSciences
The main advantage of trading using opposite SAB Biotherapeutics and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |